These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 25112279)
1. Pharmacological inhibition of DGAT1 induces sebaceous gland atrophy in mouse and dog skin while overt alopecia is restricted to the mouse. Floettmann E; Lees D; Seeliger F; Jones HB Toxicol Pathol; 2015 Apr; 43(3):376-83. PubMed ID: 25112279 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of sebaceous gland atrophy-sparing DGAT1 inhibitors. Muise ES; Zhu Y; Verras A; Karanam BV; Gorski J; Weingarth D; Lin HV; Hwa J; Thompson JR; Hu G; Liu J; He S; DeVita RJ; Shen DM; Pinto S PLoS One; 2014; 9(2):e88908. PubMed ID: 24558447 [TBL] [Abstract][Full Text] [Related]
3. Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study. Denison H; Nilsson C; Kujacic M; Löfgren L; Karlsson C; Knutsson M; Eriksson JW Diabetes Obes Metab; 2013 Feb; 15(2):136-43. PubMed ID: 22950654 [TBL] [Abstract][Full Text] [Related]
4. Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial. Denison H; Nilsson C; Löfgren L; Himmelmann A; Mårtensson G; Knutsson M; Al-Shurbaji A; Tornqvist H; Eriksson JW Diabetes Obes Metab; 2014 Apr; 16(4):334-43. PubMed ID: 24118885 [TBL] [Abstract][Full Text] [Related]
5. Leptin modulates the effects of acyl CoA:diacylglycerol acyltransferase deficiency on murine fur and sebaceous glands. Chen HC; Smith SJ; Tow B; Elias PM; Farese RV J Clin Invest; 2002 Jan; 109(2):175-81. PubMed ID: 11805129 [TBL] [Abstract][Full Text] [Related]
10. Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. Cao J; Zhou Y; Peng H; Huang X; Stahler S; Suri V; Qadri A; Gareski T; Jones J; Hahm S; Perreault M; McKew J; Shi M; Xu X; Tobin JF; Gimeno RE J Biol Chem; 2011 Dec; 286(48):41838-41851. PubMed ID: 21990351 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice. Chen HC; Farese RV Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):482-6. PubMed ID: 15569818 [TBL] [Abstract][Full Text] [Related]
12. Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol. Morentin Gutierrez P; Yates J; Nilsson C; Birtles S Pharmacol Res Perspect; 2019 Apr; 7(2):e00465. PubMed ID: 30899516 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition to examine the role of DGAT1 in dietary lipid absorption in rodents and humans. Maciejewski BS; LaPerle JL; Chen D; Ghosh A; Zavadoski WJ; McDonald TS; Manion TB; Mather D; Patterson TA; Hanna M; Watkins S; Gibbs EM; Calle RA; Steppan CM Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(11):G958-69. PubMed ID: 23558010 [TBL] [Abstract][Full Text] [Related]
14. Sebaceous Gland Atrophy in Psoriasis: An Explanation for Psoriatic Alopecia? Rittié L; Tejasvi T; Harms PW; Xing X; Nair RP; Gudjonsson JE; Swindell WR; Elder JT J Invest Dermatol; 2016 Sep; 136(9):1792-1800. PubMed ID: 27312025 [TBL] [Abstract][Full Text] [Related]
15. Sebaceous gland atrophy due to seborrheic dermatitis in a patient with alopecia: A potential pitfall. Zengin S; Guthrie J; Zoumberos N; Hamza M; Shalin SC J Cutan Pathol; 2024 Jul; 51(7):513-517. PubMed ID: 38613429 [TBL] [Abstract][Full Text] [Related]